The easiest way to crush the ASX in 2018

How Cochlear Limited (ASX:COH) and CSL Limited (ASX:CSL) beat the ASX 200 for five years running.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The numbers don't lie.

If you really want to beat the S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) and grow your wealth, health care is the only way to go.

Yes, boring old health care.

According to Deloitte, health care spending is growing around 5% annually across Asia and Australasia and is estimated to top US$8.7 trillion dollars globally in 2020 – 10.5% of global GDP. It is mind blowing stuff.

On steroids

The cash is being funneled to major health care companies at a startling rate, juicing up investment returns. Just take a look at the below comparison of the S&P/ASX 200 to the S&P/ASX 200 Health Care Index (Index: ASX: XHJ):

Source: Google Finance

Over the last five years the steroid injected S&P/ASX 200 Health Care Index has destroyed the returns of the S&P/ASX 200 by over 4x, led by big names like ResMed Inc. (CHESS) (ASX: RMD), Cochlear Limited (ASX: COH) and CSL Limited (ASX: CSL).

Too expensive?

There is a well-founded perception that health care companies are expensive. In a relative sense, when compared to the broad S&P/ASX 200 Index, this is certainly true.

The recent trailing price-to-earnings (P/E) ratio for the S&P/ASX 200 Health Care index is a huge 36.7 compared to just 18.5 for the S&P/ASX 200 Index.

Meanwhile, dividend yields for health care also trail at a stingy 1.6%, compared to 4% for the S&P/ASX 200.

This does not necessarily mean health care companies are overvalued. The industry is booming and unlike many sectors has a clear, sustainable growth outlook over the next decade. This is reflected in the projected forward P/E for the healthcare index which drops to 25.7.

According to the Australian Bureau of Statistics, 20% of Aussies will be 65 or older in 2040, from 15% in 2017, pushing one of the key markets for health care products far higher and accelerating the demand for health care locally.

This trend is similar for developed countries around the world. As people age, it is only natural that spending on quality of life should come ahead of discretionary spending, every time.

This supports the likelihood of continued above average earnings growth for companies in the industry which will naturally command above average share prices relative to earnings today. Though this also adds risk if individual companies fail to achieve expectations.

Low dividends allow reinvestment back into assets and research and development to ensure companies can keep up with growing demand and compound returns at high margins.

And boy, are margins high! CSL has an operating profit margin of 25.5% in 2017, while hearing device company Cochlear also produced operating margins of 25%.

A tick in every box

Still not convinced?

Health care stocks are not only growing at unparalleled rates and earning huge margins, but big companies like ResMed, CSL and Cochlear also have strong globally diversified earnings. This lowers geographic risk and can amplify returns from major currencies if there is a local downturn.

Health care remains an essential, defensive, growing, high margin industry. Individual companies are not infallible, but I think the industry makes it a formidable investment opportunity for smart investors.

Motley Fool contributor Regan Pearson has no position in any of the stocks mentioned. You can follow him on Twitter @Regan_Invests. The Motley Fool Australia has recommended Cochlear Ltd. and ResMed Inc. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »